The latter response indicates that STING activation initiates pathways that actively reorganize or remodel the extracellular matrix, potentially contributing to pathological conditions associated with aberrant extracellular matrix deposition or degradation, such as cancer metastasis. The gene discussed is STING1; the disease is cancer.